Joshua A. Kazam
2009
In 2009, Joshua A. Kazam earned a total compensation of $81K as President & CEO at Capricor Therapeutics.
Compensation breakdown
| Option Awards | $80,963 |
|---|---|
| Total | $80,963 |
Kazam received $81K in option awards, accounting for 100% of the total pay in 2009.
Rankings
In 2009, Joshua A. Kazam's compensation ranked 9,767th out of 9,885 executives tracked by ExecPay. In other words, Kazam earned more than 1.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,767 out of 9,885 | 1st |
Division Manufacturing | 3,644 out of 3,690 | 1st |
Major group Chemicals And Allied Products | 856 out of 871 | 2nd |
Industry group Drugs | 633 out of 643 | 2nd |
Industry Pharmaceutical Preparations | 437 out of 446 | 2nd |
Source: SEC filing on April 8, 2011.
Kazam's colleagues
We found three more compensation records of executives who worked with Joshua A. Kazam at Capricor Therapeutics in 2009.